Health Care: Drugs

Pharmacyclics Inc (PCYC: NASDAQ)

$261.25 1.7 | 0.66%
05/22/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 261.25
52 Week High 261.68
52 Week Low 86.97
Avg. Daily Vol. (Mil) 1.32
Beta (3 year) 0.55
Share Related Items
Mkt Cap (Mil) 20,136.93
Shares Out (Mil) 77.08
Float (Mil) 43.70
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.10
Current Ratio 5.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 290.20
Price/Sales 24.67
Price/Book 22.56
Price/Cash Flow 261.80
Per Share Data
Earnings 0.90
Sales 10.59
Book Value 11.58
Cash Flow 1.00
Business Summary
Pharmacyclics Inc is a biopharmaceutical companyengaged in developing and commercializing novel therapies for the treatment of cancer and immune-mediated diseases.
General Information
995 East Arques Avenue
Sunnyvale, CA 94085-4521
www.pharmacyclics.com
Industry : Drugs
Sector: Health Care
Employees: 607
CEO: Robert W. Duggan
Short Interest
Current Month (Mil) 2.57
Previous Month (Mil) 2.37
Short Interest Ratio (Days) 2.90
Management Effectiveness
Return on Equity 8.10
Return on Assets 6.40
Return on Investments 8.10
Profitability
Gross Margin 69.60
EBIT Margin 13.30
Profit Margin 8.80

Portfolios with PCYC

Latest PCYC Headlines from TheStreet

More Financial News for PCYC

Press Releases for PCYC

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter